Clinical Trial Update: Efficacy and Safety Study of Sulfonylureas in Neonatal Diabetes Mellitus [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy and safety of sulfonylureas in neonatal diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Diabetes Mellitus

Drugs mentioned

• Glibenclamide (glibenclamide)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Diabetes Mellitus | Phase 2 | Status: COMPLETED